Gene · 3959
LGALS3BP: galectin 3 binding protein
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. LGALS3BP: galectin 3 binding protein. Genes, record 3959. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3959
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q08380 | Galectin-3-binding protein | 585 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents144
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 51202 | Q08380 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 2115 | Q08380 | Espacenet |
| WO 2025228986 A1 | 2025-11-06 | 68 | Q08380 | Espacenet |
| EP 4644537 A1 | 2025-11-05 | 68 | Q08380 | Espacenet |
| US 12448654 B2 | 2025-10-21 | 3 | Q08380 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 7800 | Q08380 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 6883 | Q08380 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 6883 | Q08380 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 2115 | Q08380 | Espacenet |
| EP 4549941 A1 | 2025-05-07 | 10 | Q08380 | Espacenet |
1 to 10 of 144
See all 144 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,433
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | LGALS3BP papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| P30AI027763 | UCSF-Bay Area Center for AIDS Research | 5 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| P30AI036219 | Rustbelt Center for AIDS Research (Case/UHC-Pitt CFAR) | 4 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 4 | 2025 |
| R01CA160254 | Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach | 4 | 2025 |
| P30AI050410 | The University of North Carolina Center for AIDS Research | 3 | 2025 |
| P30CA014195 | Cancer Center Support Grant (CCSG) | 3 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 3 | 2025 |
| P30ES013508 | Center of Excellence in Environmental Toxicology | 3 | 2025 |
1 to 10 of 1,433Source NIH's project files
See all 1,433 nih grantsPapers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical utility of serum Mac-2 binding protein glycosylation isomer as a noninvasive marker for liver fibrosis in biliary atresia. | J Pediatr Surg | 2026 | 42632410 | PubTator, text mining | PubMed |
| Circulating Protein Biomarkers for Primary Cardiomyopathy: Evidence from Mendelian Randomization and Clinical Validation. | Anatol J Cardiol | 2026 | 42552772 | PubTator, text mining | PubMed |
| MZT2A drives epithelial-mesenchymal transition in lung adenocarcinoma via the LGALS3BP/ITGB1/TGF-β/smad2 axis. | iScience | 2026 | 42502396 | PubTator, text mining | PubMed |
| Protein signatures for the early detection of endometrial cancer in cervico-vaginal fluid. | Expert Rev Mol Diagn | 2026 | 42460670 | PubTator, text mining | PubMed |
| Multilayer Validation Reveals a Glia-Associated Secretome Signature in Temporal Lobe Epilepsy. | J Mol Neurosci | 2026 | 42435258 | PubTator, text mining | PubMed |
| Unveiling potential natural promoters of calcium oxalate kidney stones in the urine via anion-exchange chromatography, crystal assays, and proteomics. | Mol Cell Biochem | 2026 | 42418121 | PubTator, text mining | PubMed |
| Translational insights into extracellular vesicles in peritoneal dialysis. | Perit Dial Int | 2026 | 42396861 | PubTator, text mining | PubMed |
| Association of Serum Lectin Galactoside-Binding Soluble 3-Binding Protein with Acute Exacerbation, Inflammation, and Airway Remodeling in Pediatric Asthma. | Int Arch Allergy Immunol | 2026 | 42378190 | PubTator, text mining | PubMed |
| Extracellular vesicle cargo dynamics in the bone marrow microenvironment: from hematopoietic homeostasis to malignant transformation. | Extracell Vesicle | 2026 | 42344609 | PubTator, text mining | PubMed |
| Optimization of polyethylene glycol-based isolation of exosomes from mesenchymal stem cells for regenerative medicine applications. | Stem Cell Res Ther | 2026 | 42289727 | PubTator, text mining | PubMed |
1 to 10 of 2,653
See all 2,653 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3959
GET https://conductscience.org/api/genes/v1/3959/patents?page=2